Physician Continuing Medical Education
Accreditation Statement
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Postgraduate Institute for Medicine and the Society for Immunotherapy of Cancer. Postgraduate Institute for Medicine is accredited by the ACCME to provide continuing medical education for physicians.
Credit Designation
Postgraduate Institute for Medicine designates this live activity for a maximum of 5.5 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Pharmacist Continuing Education
Accreditation Statement
Postgraduate Institute for Medicine is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.
Credit Designation
Postgraduate Institute for Medicine designates this continuing education activity for 5.5 contact hours (0.55 CEUs) of the Accreditation Council for Pharmacy Education.
Universal Activity Number: 0809-9999-17-450-L01-P
Type of Activity: Knowledge
For Pharmacists: Upon receipt of the completed activity evaluation form, you will receive an email from Postgraduate Institute for Medicine within four weeks with a link and directions to submit your credit to the NABP CPE Monitor Service.
Nursing Continuing Medical Education
Postgraduate Institute for Medicine is accredited with distinction as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation. This educational activity for 5.4 contact hours is provided by Postgraduate Institute for Medicine. Designated for 2.4 contact hours of pharmacotherapy credit for Advance Practice Registered Nurses.
California Board of Registered Nursing
Provider approved by the California Board of Registered Nursing, Provider Number 13485, for 5.4 contact hours.
Disclosure of Conflicts of Interest
Postgraduate Institute for Medicine (PIM) requires instructors, planners, managers and other individuals who are in a position to control the content of this activity to disclose any real or apparent conflict of interest (COI) they may have as related to the content of this activity. All identified COI are thoroughly vetted and resolved according to PIM policy. The existence or absence of COI for everyone in a position to control content will be disclosed to participants prior to the start of each activity.
Educational Objectives
Upon completion of this program, participants will be able to:
- Describe the rationale for common approaches to cancer immunotherapy.
- Identify the appropriate clinical management of common side effects of immunotherapy agents.
- Implement cancer immunotherapy treatments for melanoma, lung, genitourinary, head and neck, and/or hematologic cancers into clinical practice appropriately.
- Identify solutions to overcome operational and financial barriers to integrating immunotherapy into their practice setting.
- Provide appropriate care and counsel for patients receiving immunotherapy and their families.
- Provide accurate and appropriate counsel on immunotherapy as part of the treatment team.